ANA ADELA RAMÍREZ BOSCÁ,DANIEL RAMÓN VIDAL,FRANCISCO MANUEL CODOÑER CORTÉS,JOSÉ MANUEL PÉREZ ORQUÍN,MARÍA EMPAR CHENOLL CUADROS,SALVADOR GENOVÉS MARTÍNEZ,VICENTE MANUEL NAVARRO LÓPEZ
申请号：
BR112019001116
公开号：
BR112019001116A2
申请日:
2017.07.18
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention is for use in a probiotic composition comprising bifidobacterium animalis subs. lactis (b. lactis), bifidobacterium longum and lactobacillus casei, particularly strains b. lactis cect 8145, b. longum cect 7347 and / or 1. casei cect 9104, in the treatment and / or prevention of atopic dermatitis.a presente invenção destina-se ao uso de uma composição probiótica compreendendo bifidobacterium animalis subs. lactis (b. lactis), bifidobacterium longum e lactobacillus casei, particularmente as cepas b. lactis cect 8145, b. longum cect 7347 e/ou l. casei cect 9104, no tratamento e/ou prevenção da dermatite atópica.
